Page 50 - The prevalence of the Val66Met polymorphism in musicians: Possible evidence for compensatory neuroplasticity from a pilot study
P. 50

https://doi.org/10.1101/2022.10.10.511614
 doi:
 bioRxiv preprint
        The copyright holder for this preprint
 this version posted October 13, 2022.
 ;
 (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
 available under a
 .
 CC-BY-ND 4.0 International license
                                                                                        15


 100%
      100%





        90%






        80%
 80%






 Call Rate  Concordance  70%




        60%



 60%

        50%






        40%






 40%    30%
 0  125  375  625  1000  0        125            375           625           1000
                                                           2
 Dosage (mJ/cm )                        Dosage (mJ/cm )
 2
 C    NA12878  NA24631    D         NA12878           NA24631

 Figure 2
 (A) Degradation index (DI) values across all dosage intervals. Dosage of 0 mJ/cm  indicated control sample with no UV treatment applied.  (B) Example of STR
 2
 electropherograms showing increased degradation with increasing treatment dosages (0, 375, and 1000 mJ/cm ) in a single dye channel. The data was analyzed at a
                                 2
 minimum analytical threshold of 50 RFU. “No exposure” demonstrates a ‘normal’ distribution of peak heights, while 375 mJ/cm  treatment exhibits the ‘ski-slope’ pattern
                                                  2
 typically observed with degraded DNA samples. Treatment at 1000 mJ/cm  exhibits the same sloped pattern in addition to allelic drop-out, suggesting greater DNA
 2
 degradation. (C) Call Rates as it relates to the amount of UV dosage. Each line represents a replicate of the two DNA standards used in the study. (D) Sample concordance
 of each of the UV-C treated samples as compared back to the 20 ng control sample. Each line represents a replicate of the two DNA standards used in the study.




 Developmental Validation of the Illumina Infinium Assay using the Global Screening Array (GSA) on the iScan System for use in Forensic Laboratories
   45   46   47   48   49   50   51   52   53   54   55